Kyverna Therapeutics, Inc. (KYTX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $232.28M | -12.9% |
| 2024 | $266.59M | +2129.0% |
| 2023 | -$13.14M | +82.2% |
| 2022 | -$74.00M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $232.28M | -12.9% |
| 2024 | $266.59M | +2129.0% |
| 2023 | -$13.14M | +82.2% |
| 2022 | -$74.00M | — |